FDNA to Launch Third Cycle of GIVE A FACE TO A SYNDROME at the ACMG Annual Meeting

March 7, 2016

Call for Research Proposals Issued at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting 2016

FDNA Inc. (Boston, MA) issued today a call to geneticists to submit research proposals to the third cycle of the GIVE A FACE TO A SYNDROME research program. The announcement coincides with the American College of Medical Genetics and Genomics (ACMG) Annual Meeting.

The third cycle of this research program will focus on the use of FDNA’s standardized and deep phenotyping technology, available through Face2Gene, to associate phenotypic features with genetic variants, demonstrating the potential of improved diagnostic yield of variant analysis.

“After the overwhelmingly positive outcome of the two previous cycles, resulting in numerous publications, talks and abstracts in some of the most prestigious venues in the world, we decided to further strengthen our partnership with the genetic research community,” said Nicole Fleischer, Head of Research Collaborations at FDNA.

Individuals and institutions interested in joining the third cycle of the GIVE A FACE TO A SYNDROME research program should submit a short proposal by 5:00 PM Eastern time on June 30, 2015. The call for research proposals is available to all geneticists worldwide and does not include financial support. Study results will be shared with the scientific community and may serve as the basis for scientific publication by the collaborators. Collaborators will receive full credit for their participation in the program. Applicants are invited to submit proposals in this link https://fdna.com/rfp/

Questions can be directed to info(at)fdna.com, or stop by booth #505 at the American College of Medical Genetics and Genomics (ACMG) Annual Meeting in Tampa, Florida, March 9-11.

Related articles

Genetic Research in Africa: An Interview

Genetic Research in Africa: An Interview with Dr. Aime Lumaka

Dr. Aime Lumaka, a distinguished geneticist from the Democratic Republic of Congo, is at the forefront of advancing genetic research across Africa. As a pivotal figure in the Deciphering Developmental Disorders in Africa (DDD-Africa) initiative and the Principal Investigator of the African Rare Diseases Initiative (ARDI), Dr Lumaka is leading efforts to evaluate clinical exome sequencing in […]

Continue reading
Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

Pioneering Rare Disease Diagnosis in Italy with AI-Powered Innovations, in Dermatology and Genetics

In a recent landmark scientific webinar trailblazing development in dermatological phenotyping, genetic disorders, and the transformative application of artificial intelligence (AI) in rare disease diagnostics in Italy were explored. The event convened leading experts, researchers, and clinicians, who unveiled their experience in the clinic, including the innovative use of an AI-powered called Face2Gene to significantly […]

Continue reading